DiscoverMelanoma Insights for ProfessionalsUtilising melanoma risk prediction tools for newly diagnosed patients
Utilising melanoma risk prediction tools for newly diagnosed patients

Utilising melanoma risk prediction tools for newly diagnosed patients

Update: 2025-08-15
Share

Description

In this episode, we explore how melanoma risk prediction tools are transforming clinical decision-making for newly diagnosed patients. These tools, developed by Melanoma Institute Australia and freely available at melanomarisk.org.au, help clinicians tailor care and improve outcomes.

Our multidisciplinary experts provide practical guidance on using tools to predict sentinel node metastasis, recurrence risk and more. Through real-world case examples and expert insights, this episode offers valuable strategies for integrating personalised risk assessment into your practice.


This podcast is suitable for multidisciplinary specialists, primary care physicians and other healthcare professionals.


Resources:


Speakers:

  • Prof Anne Cust - Cancer Epidemiologist and Faculty Member, Melanoma Institute Australia | Interim Director, Daffodil Centre | Chair, Cancer Council National Skin Cancer Committee


  • A/Prof Alex Varey - Plastic and Reconstructive Surgeon, Melanoma Institute Australia and Westmead Hospital | Clinical Associate Professor, The University of Sydney


  • A/Prof Linda Martin - Director of Dermatology Services, Melanoma Institute Australia | Staff Specialist, Sydney Children’s Hospital | Associate Professor of Dermatology, University of NSW


Please note that this podcast was accurate at the time of recording (August 2025) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.


MIA’s Education Program is proudly supported through unrestricted educational grants from BMS, MSD and HEINE.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Utilising melanoma risk prediction tools for newly diagnosed patients

Utilising melanoma risk prediction tools for newly diagnosed patients

Melanoma Institute Australia